BT
BioRestorative Therapies, Inc.
SEC filingBiotechnology · Melville, NY
Amount raised$1.4Msold at filing
Total offering$1.4M
Investors in the raise16count reported to the SEC
FiledOct 9, 2025first sale Oct 8, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Nickolay V KukekovDirector
Robert KristalExecutive Officer
Francisco SilvaDirector, Executive Officer
Patrick F WilliamsDirector
David A RosaDirector
Lance AlstodtDirector, Executive Officer
Executive officers, directors and promoters as listed on the Form D.